The cash price for popular weight-loss medications Wegovy and and the medication authorized for people with type 2 diabetes Ozempic are dropping by 30% in U.S. on Monday, according to Novo Nordisk, the pharmaceutical company that manufactures both drugs. https://t.co/AbYivGsSmc